Correlation Between Champions Oncology and Pharvaris

Can any of the company-specific risk be diversified away by investing in both Champions Oncology and Pharvaris at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Champions Oncology and Pharvaris into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Champions Oncology and Pharvaris BV, you can compare the effects of market volatilities on Champions Oncology and Pharvaris and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Champions Oncology with a short position of Pharvaris. Check out your portfolio center. Please also check ongoing floating volatility patterns of Champions Oncology and Pharvaris.

Diversification Opportunities for Champions Oncology and Pharvaris

-0.5

Correlation Coefficient

Champions Oncology  Pharvaris

Very good diversification

The 3 months correlation between Champions and Pharvaris is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding Champions Oncology and Pharvaris BV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharvaris BV and Champions Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Champions Oncology are associated (or correlated) with Pharvaris. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharvaris BV has no effect on the direction of Champions Oncology i.e., Champions Oncology and Pharvaris go up and down completely randomly.

Pair Corralation between Champions Oncology and Pharvaris

Given the investment horizon of 90 days Champions Oncology is expected to generate 1.88 times less return on investment than Pharvaris. In addition to that, Champions Oncology is 1.11 times more volatile than Pharvaris BV. It trades about 0.05 of its total potential returns per unit of risk. Pharvaris BV is currently generating about 0.11 per unit of volatility. If you would invest  1,755  in Pharvaris BV on September 3, 2024 and sell it today you would earn a total of  435.00  from holding Pharvaris BV or generate 24.79% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Champions Oncology  vs.  Pharvaris BV

Champions Oncology

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Champions Oncology are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating fundamental drivers, Champions Oncology reported solid returns over the last few months and may actually be approaching a breakup point.

Pharvaris BV

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Pharvaris BV are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Pharvaris unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Champions Oncology and Pharvaris

The main advantage of trading using opposite Champions Oncology and Pharvaris positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Champions Oncology position performs unexpectedly, Pharvaris can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharvaris will offset losses from the drop in Pharvaris' long position.

The idea behind Champions Oncology and Pharvaris BV pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.